Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Dr. Orkin discusses results from key studies reported at AIDS 2020: Virtual, with new data on the following hot topics: current ART in principal populations, including older patients and women who become pregnant; metabolic outcomes during ART; HIV and COVID-19; investigational ART strategies; and HIV prevention. The overview includes:
Content based on a CME program supported by independent educational grants from Gilead Sciences, Merck Sharp & Dohme Corp., and ViiV Healthcare.
Link to full program: https://www.clinicaloptions.com/hiv/conference-coverage/aids-2020
Professor of HIV
Queen Mary, University of London
Lead for HIV Research
Barts Health NHS Trust
The Royal London Hospital
London, United Kingdom
Senior Scientific Director
Executive Vice President
This program has been made available online.
Expert insights on HIV PrEP medications, guideline updates, and solutions to uptake barriers, from Dr Gregory Huhn and Clinical Care Options (CCO)
Clinical Care Options (CCO) expert Carolyn Chu, MD, MSc, discusses how to improve HIV pre-exposure prophylaxis accessibility and availability for PWID
Drs. Jean Rene Anderson and William Short speak to the balancing act when considering HIV treatments during pregnancy, from Clinical Care Options (CCO)